An interventional study of Computerized attentional bias modification training and Placebo attention control training in E-cigarette Use and Tobacco Use Cessation, sponsored by University of Wisconsin, Milwaukee. Status unknown at 1 site in United States. Open to participants aged 18 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-04.
Sponsored by University of Wisconsin, Milwaukee · Not applicable, Interventional, and Treatment
Aims are to (1) evaluate attentional bias to e-cigarette cues between the intervention and control groups at post-intervention as compared to the pre-intervention; and (2) test the feasibility and efficacy of the intervention at post-intervention. To accomplish these aims, a theory-driven parallel, controlled 2-arm randomized clinical trial will be conducted with young adult e-cigarette users (approximately N = 50). Outcomes are attentional bias to e-cigarette cues and abstinence outcomes including nicotine dependence, and arousal/urges for e-cigarette use.
University of Wisconsin, Milwaukee is the lead sponsor of 33 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Behavioral: Computerized attentional bias modification training
Behavioral: Placebo attention control training
In intervention is designed to train participants to disengage attention from potent e-cigarette cues and is based on the well-established attention retraining paradigm for other psychopathologies.
This control training is very similar to the intervention's overall task structure and stimuli. The only difference is that the this control program is designed to exert no systematic manipulation on the attention deployment pattern between the two stimulus categories, thereby yielding no significant impact on the level of attentional bas toward ENDS-related cues
Attentional bias to e-cigarette cues measured by cueing task
Attentional bias measured by time in milliseconds between cue and response in cueing task
Time frame: Pre-training
Attentional bias to e-cigarette cues measured by cueing task
Attentional bias measured by time in milliseconds between cue and response in cueing task
Time frame: 1-month follow up
Attentional bias to e-cigarette cues measured by cueing task
Attentional bias measured by time in milliseconds between cue and response in cueing task
Time frame: 2-months follow up
Attentional bias to e-cigarette cues measured by cueing task
Attentional bias measured by time in milliseconds between cue and response in cueing task
Time frame: 4-months follow up
Subjective urges for e-cigarette use
Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire)
Time frame: Pre-training
Nicotine dependence
Nicotine dependence measured by Penn State E-Cigarette Dependence Index
Time frame: Pre-training
Subjective urges for e-cigarette use
Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire)
Time frame: 1-momnth follow up
Nicotine dependence
Nicotine dependence measured by Penn State E-Cigarette Dependence Index
Time frame: 1-month follow up
Subjective urges for e-cigarette use
Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire)
Time frame: 2-momnth follow up
Nicotine dependence
Nicotine dependence measured by Penn State E-Cigarette Dependence Index
Time frame: 2-month follow up
Subjective urges for e-cigarette use
Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire)
Time frame: 4-momnth follow up
Nicotine dependence
Nicotine dependence measured by Penn State E-Cigarette Dependence Index
Time frame: 4-month follow up
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Milwaukee